seasonal inactivated influenza vaccine (Johns Hopkins Bloomberg School of Public Health)

This refers to a quadrivalent seasonal inactivated influenza vaccine utilized in a pilot clinical research study conducted by the Johns Hopkins Bloomberg School of Public Health. The study specifically investigates the vaccine's impact on early immune responses (cytokines) and reproductive hormone levels in healthy women, testing the hypothesis that the timing of vaccine administration relative to ovulation may influence subsequent hormonal profiles. As an inactivated vaccine, it contains killed influenza virus particles (typically two A strains and two B strains) that stimulate the production of neutralizing antibodies against the viral hemagglutinin protein, providing active immunity against seasonal influenza without the risk of causing the disease.

Other names

Quadrivalent seasonal inactivated influenza vaccineSeasonal flu shotseasonal inactivated influenza vaccine-Johns Hopkins Bloomberg School of Public Health-influenza